DXR
Daxor Corporation
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$10.27
−2.66%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- 6.44x
- PEG TTM
- 0.15x
- Price / book
- 1.16x
- Price / sales
- 69.04x
- Price / cash flow
- -21.11x
Enterprise value
- Enterprise value
- $54.2M
- EV / sales
- 62.37x
- EV / EBITDA
- 5.66x
- EV / EBIT
- 6.63x
- Market cap
- $60.0M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026